BamSEC and AlphaSense Join Forces
Learn More

Abbott Biotherapeutics Corp

Material Contracts Filter

EX-10.1
from 10-Q/A 125 pages Collaboration and License Agreement
12/34/56
EX-10.25
from 10-K 5 pages Confidential Provisions Redacted Amendment No. 2 to Asset Purchase Agreement
12/34/56
EX-10.22
from 10-K 4 pages Second Amendment to the Collaboration Agreement
12/34/56
EX-10.1
from 8-K 12 pages Stockholders Agreement
12/34/56
EX-10.1
from 8-K 12 pages Stockholders Agreement
12/34/56
EX-10.2
from 10-Q 6 pages Confidential Provisions Redacted Amendment No. 2 to Clinical Drug Substance Supply Agreement
12/34/56
EX-10.1
from 10-Q 88 pages Collaboration and License Agreement
12/34/56
EX-10.27
from 10-K 5 pages Second Amendment to Triple Net Space Lease
12/34/56
EX-10.26
from 10-K 2 pages First Amendment to Triple Net Space Lease
12/34/56
EX-10.24
from 10-K 5 pages Second Amendment to Triple Net Space Lease
12/34/56
EX-10.23
from 10-K 2 pages First Amendment to Triple Net Space Lease
12/34/56
EX-10.20
from 10-K 3 pages November 13, 2008 Mark McCamish [***] [***] Re: Retention Bonuses Retention Bonuses
12/34/56
EX-10.19
from 10-K 3 pages November 13, 2008 Maninder Hora [***] [***] Re: Retention Bonuses and Severance Benefits Retention Bonuses
12/34/56
EX-10.18
from 10-K 3 pages November 13, 2008 Andrew Guggenhime [***] [***] Re: Retention Bonuses Retention Bonuses
12/34/56
EX-10.17
from 10-K 2 pages Material contract
12/34/56
EX-10.16
from 10-K 2 pages Material contract
12/34/56
EX-10.15
from 10-K 2 pages Material contract
12/34/56
EX-10.14
from 10-K 4 pages Material contract
12/34/56
EX-10.12
from 10-K 2 pages Agreement to Participate in the Facet Biotech Corporation Retention and Severance Plan Effective December 18, 2008
12/34/56
EX-10.11
from 10-K 2 pages Agreement to Participate in the Facet Biotech Corporation Retention and Severance Plan Effective December 18, 2008
12/34/56